Nothing Special   »   [go: up one dir, main page]

Sehon et al., 1979 - Google Patents

Suppression of immunoglobulin E antibodies with modified allergens

Sehon et al., 1979

Document ID
17415099184000056757
Author
Sehon A
Lee W
Publication year
Publication venue
Journal of Allergy and Clinical Immunology

External Links

Snippet

Since the demonstration in 1966'that the skin-sensitizing activity of the serum of a ragweed- allergic patient was due to antibodies belonging to the then newly discovered and distinct class of IgE immunoglobulins,'-'it has been generally recognized that common forms of …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • A61K47/4833—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Shakib et al. Human IgG subclasses in health and disease (A review) Part II
US4261973A (en) Allergen-containing substances
Lee et al. Suppression of reaginic antibodies with modified allergens: I. Reduction in allergenicity of protein allergens by conjugation to polyethylene glycol
Lee et al. Suppression of reaginic antibodies with modified allergens: II. Abrogation of reaginic antibodies with allergens conjugated to polyethylene glycol
BOREL Induction of immunological tolerance by a hapten (DNP) bound to a non-immunogenic protein carrier
Wie et al. Suppression of Reaginic Antibodies with Modified Allergens: III. Preparation of Tolerogenic Conjugates of Common Allergens with Monomethoxypolyethylene Glycols of Different Molecular Weights by the Mixed Anhydride Method
GB1599454A (en) Antigen-d-glutamic acid d-lysine copolymer conjugates for induction of immunological tolerance
Chiorazzi et al. Induction if immunological tolerance to the major antigenic determinant of penicillin: a therapeutic approach to penicillin allergy.
Sehon et al. Suppression of immunoglobulin E antibodies with modified allergens
US5026545A (en) Treatment of allergy and composition therefor
van der Giessen et al. The subclasses of human IgG antibodies against tetanus toxoid.
US5079344A (en) Antigenic epitopes present on membrane-bound but not secreted IgA
US4269764A (en) Preparation for treatment of allergic patients sensitive to ragweed pollen
Goldschmidt et al. The immune response to homologous lens crystallin. I. Antibody production after lens injury.
Filion et al. Suppression of the IgE antibody response to ovalbumin in mice with a conjugate of ovalbumin and isologous γ-globulins
Desaymard Role of epitope density in the induction of immunity and tolerance with thymus‐independent antigens IV. Selective tolerance of IgE response by DNP‐levan conjugates
Kam et al. Effects of tolerogenic conjugates in a canine model for reaginic hypersensitivity: I. Suppression of hapten-specific IgE antibody response
Ekramoddoullah et al. Isolation of a purified allergen from Kentucky blue grass pollen
EP0504136A1 (en) Tolerogenic immunoglobulin-protein conjugates
Iverson et al. Immunological paralysis induced by an idiotypic antigen
Ishizaka et al. Immunoglobulin E: Biosynthesis and immunological mechanisms of IgE-mediated hypersensitivity
AU2002242447B2 (en) Use of polyclonal immunoglobulins
Babakhin et al. Immunological properties of allergen chemically modified with synthetic copolymer of N-vinylpyrrolidone and maleic anhydride
Hellman Is vaccination against IgE possible?
Lee et al. Abrogation of the antibenzylpenicilloyl (BPO) IgE Response with BPO-polyvinyl alcohol conjugates